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Detection of Australia Antigen (HBAg) in Blood
Donors and Hepatoma Patients in Mozambique
L. L. REYS, O. A. SEQUElltA
SUMMARY
The evaluation of three different methods (counter
immuno-electrophoresis, latex agglutination and radio-
immunoassay) for Australia antigen detection is discussed
with regard to their sensitivity in the analysis of sera
from blood donors and primary liver cancer patients.
The counter immuno-electrophoretic method is the least
sensitive, particularly in the analysis of sera from hepatoma
patients. The latex agglutination test seems to have the
same reliability in both groups, but gave a higher per-
centage of positive results compared with the radio-
immunoassay technique.
The value of an improved latex agglutination test for
Australia antigen detection in field work in southern
Mozambique, is stressed.
S. Afr. Med. J" 48, 267 (1974).
The transfusion of blood containing hepatitis B antigen
(HBAg) is associated with the development of acute,'
chronic' or anicteric' hepatitis. Evidence has been accumu-
lated in recent years that HBAg is highly prevalent in pri-
mary liver carcinoma (PLC)' and other diseases.'" For
these reasons, many blood banks are introducing the detec-
tion of HBAg as a compulsory screening test in blood
donors. A simple, quick, inexpensive and reliable method;
which would require a minimum of equipment and quali-
fied personnel, is most desirable, particularly in countries
where high frequencies of HBAg prevail, especially when
the demand for blood units exceeds the supply.
Most of the serological methods available for HBAg
detection are not suitable for use as a routine test in
blood banks, either because they require very sophisticated
techniques or because of prohibitive costs. Of the current
serological methods, the latex agglutination test (LAT)
should be most adequate, and different laboratories are
trying to use it for HBAg detection."s We had the
opportunity of trying one of these tests, developed by
Pfizer Laboratories and to compare it with the counter
immuno-electrophoresis (CIEP) and radio-immunoassay
(RIA) techniques in the detection of HBAg in blood
donors and PLC patients in Mozambique.
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MATERIALS AND METHODS
Sixty-four serum samples were collected from 35 blood
donors and 29 PLC patients. After the addition of a drop
of 5% sodium azide solution, they were kept frozen at
- 20°C until tested.
The CIEP technique was performed according to Pesen-
dorfer et al.,' with minor modifications. The antiserum
used in this test was obtained from a White patient
with haemolytic anaemia of unknown aetiology, who had
received more than 60 transfusions. This antiserum gave
an identification reaction with reference antiserum kindly
supplied by the Institute for Cancer Research of Phil-
adelphia.
Pfizer's HAA Detection Latex Reagent (Lot No. L 12/3),
still on trial evaluation and supplied by the manufacturers.
was used according to their instructions. l.'he reactions
were considered positive when agglutination of latex-sensi-
tised particles became visible within 3 minutes, without
any visual aids. In every run negative and positive controls
were included, and all doubtful results repeated.
The RIA was performed with the Abbott's Ausria':!5
kit of reagents. The cutoff is defined as the product of
the mean of the CPM values of negative controls, included
in every run, times a 2, I factor.
Blood samples were obtained from the blood bank of
Hospital Miguel Bombarda (Lourenco Marques), and
from patients with confirmed diagnoses of PLC.
RESULTS AND DISCUSSION
The results of the samples analysed by the 3 methods are
summarised in Table I. The percentage of HBAg positives
detected by either of the 3 methods is much higher in the
liver cancer group than among the blood donors, which
confirms the results found in the literature.'
Of 64 samples examined by the 3 methods, the results
were coincident in 41 cases, 8 being positive and 33 nega-
tive. The 8 coincident cases averaged high CPM values in
the RIA method.
However, some of the sera with very high counts in
RIA did not react in CIEP.
Considering RIA as one of the most reliable methods
now available for detection of HBAg,'· the ratios CIEP/
RIA and LAT/RIA show that CIEP systematically detected
fewer positive samples than RIA, while the opposite was
observed with LAT. In other words, while CIEP is prone
to give a high percentage of false negative results, the





(Byvoegsel-Sl/id-Afrikaanse Tydskrif vir Laboratoril/m- ell Kliniekwerk)
13 Februarie 1974
TABLE I. RESULTS OBTAINED IN 64 SERA SAMPLES ANALYSED FOR HBAg BY 3 DIFFERENT METHODS
No. of positive results
No. of samples Ratio Ratio
Group examined CIEP LAT RIA CIEP/RIA LAT/RIA
Blood donors 35 4 7 5 111,25 1/0,75
PLC patients 29 4 21 18 1/4,50 1/0,86
Both groups 64 8 28 23 1/2,87 1/0,82
* Numbers in brackets are the ratio between the actual CPM values
of the blood specimens and the mean CPM of negative control
samples. The value of 2.1 defines the threshold of positivity.
TABLE 11. TWENTY-THREE SAMPLES WHERE THE RESULTS
WERE NOT COINCIDENT BY THE 3 METHODS FOR
HBAg DETECTION
of these, could or have been found to reduce the
number of false positive results in the LAT method. These
precautions were not taken in the present study.
The 23 cases where the results were not coincident by
the 3 methods employed, are summarised in Table n.
All the samples gave systematically negative results in
CIEP, thus confirming its lower sensitivity in relation to
the other two. Seven samples reacted positively with LAT
and negatively with RIA, while 3 serum specimens positive
with RIA were negative with LAT. The remaining cases
were coincident by LAT and RIA techniques.
The 3 samples RlA positive and LAT negative raise
the question of false negatives in the last method. The fact
that their CPM values were near the cutoff, i.e. at the
threshold of positivity, does not permit a definite conclu-
sion. The electron microscopical examination of these sera















































The ratio LAT/RIA is more uniform in the 2 groups
examined, than CIEP/RIA. It is possible that HBAg
detection by CIEP depends, in comparison with LAT and
RIA methods, on more stringent conditions such as the
source of antiserum and its antibody titre and subtypes,
the BBAg subtypes and concentration in the samples to
be tested, the technical details involved in tbe electra-
phoretical procedure," and other unknown factors. The
ClEP technique is less suitable for a blood bank service,
where there is a need for rapid clearance of the blood
units collected.
On the other hand, the LAT method presently tried
seemed to give a more constant ratio towards the RIA
in both groups. If its margin of error is biased exclusivelv
towards false positives, it could be used safely as a quick
preliminary screening test, which would allow the imme-
diate clearance of all negative blood units, while the positive
ones could be rechecked by more reliable techniques, such
as the RJA. The possibility of false negative results by
LAT cannot, however, be excluded with confidence at
present.
From the discrepancy found in the ratio ClEP/RIA
in the 2 groups examined, it seems that ClEP detects more
HBAg positives among the blood donors than in PLC
patients, in spite of HBAg titres being higher in PLC
patients.
It is known that either RlA or LAT techniques are
more sensitive in detecting the ad than the ay subtypes
of HBAg. While the incidence of ad and ay subtypes of
BBAg is more or less the same in acute hepatitis patients,
ad is much more common in chronic hepatitis and also
in HBAg blood donor carriers." Furthermore, it is now
being realised that HBAg subtypes tend to follow a
different pattern of geographical distribution." The pre-
liminary results of the analysis carried out in tbe HBAg
positive samples included in the present work did not
support a significant difference of their incidence in
either of the groups studied.
The discrepancy observed could be due to the fact that
prozone occurred more frequently. in the PLC patients'
sera. However, other mechanisms cannot be excluded.
It is known that some factors, like the rheumatoid factor
(RF) and complement, may mask the Australia antigen
in certain methods.
The higher percentage of positive cases found by LAT
in relation to RlA, is commonly attributed to false positive
reactions.]· Some precautions such as, for instance, clotting
the test blood samples in the presence of thrombin, the
addition of mercapto-ethanol to sera with high RF titres,
vigorous shaking of the LAT reagent bottle, elimination
of bacteriological con lamination of the samples, etc., all
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Summing up, it can be said that the ClEP method, as
employed in the present study, is not suitable for routine
screening of HBAg among blood donors, and it seems
even less sensitive with regard to PLC patients' sera.
The LAT technique, if improved in its specificity, could
be a more valuable test for blood bank routine screening
of blood donors. Furthermore, if any role by HBAg in
the pathogenesis of PLC is confirmed, it would be most
desirable to have a quick method for its detection, not
only in blood banks but also for field work, particulary
in southern Mozambique, where the world's highest in-
cidence of PLC is found" in a well-defined spatial dis-
tribution pattern."
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Evaluasie van Wegdoenbare Plastiese Pipette vir
Gebruik in die Besinkingstoets
F. P. R. DE VILLIERS, A. C. MULLER
SUMMARY
Disposable plastic pipettes (Dispettes) are commercially
available for the ESR test. The results of the standard
Westergren and the Dispette methods were statistically
compared. A rapid method was also investigated, but was
shown to be too erratic for clinical use.
The l-hour Dispette method yields results which are
comparable to those of the standard Westergren method.
Dispettes have several advantages: they lessen the danger
of mouth contact with blood, thus diminishing the possi-
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bility of contracting hepatitis; they are easier to set up
accurately, and there is less danger of spilling blood; and
they are disposable.
S. A/I'. Med. J., 48, 269 (1974).
Die Internasionale Komitee vir Standardisasie in Hema-
tologie se paneel oor die besinkingstoets het "n internasio-
nale verwysingsmetode vir die doen van bloedbesinkings
opgestel.'
Die resuItaat van die besinkingstoets hang af van die
wisselwerking tussen 'n aantal inherente veranderIikes
(bv. die aantal en vorm van die rooiseIle, die relatiewe
konsentrasie van plasmaprote'iene). Sekere omgewings-
en tegniese faktore mag ook die toets be'invloed, n
Standaardmetode is nodig om sulke faktore uit te skakel.
Die paneel wys daarop dat verdere ondersoeke t.O.V.
buise wat van 'n ander stof as glas gemaak is, koIleksie
